Trans and non-binary people to be included in menopause guidance, NICE announces.
For the first time, trans and non-binary people will be included in NICE guidance on the menopause, the organisation has announced. The current guidance, last updated in 2019, is aimed at “women in menopause” meaning – as with many other gendered services such as prostate screening – trans and non-binary people were left out of the conversation.
To help change this, on 27 May, NICE published a summary of its updated guidelines which will be aimed at “women, non-binary and trans people with menopause”. The guidelines will be finalised next year and will also include advice on “managing menopause symptoms in trans and non-binary people who are taking cross-sex hormones for treatment of gender dysphoria, including those who are medically transitioning”.